机构:[1]Department of Liver Diseases, The Third People's Hospital of Kunming City, Kunming, Yunnan, People's Republic of China.[2]Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.[3]Department of Preventive Medicine, School of Public Health and Management, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Health
Commission of Kunming city (Grant No. 2020-03-08-112).
Dr. Jun Zhao received a grant from Hubei University of
Medicine (Grant No. 2018QDJZR14).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|3 区医学
小类|4 区肿瘤学
最新[2025]版:
大类|4 区医学
小类|4 区肿瘤学
第一作者:
第一作者机构:[1]Department of Liver Diseases, The Third People's Hospital of Kunming City, Kunming, Yunnan, People's Republic of China.[2]Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Dai Jingyi,Zhao Jun,Du Yingrong,et al.Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China[J].Cancer management and research.2020,12:6209-6220.doi:10.2147/CMAR.S259195.
APA:
Dai Jingyi,Zhao Jun,Du Yingrong,Zhuang Lin,McNeil Edward B&Chongsuvivatwong Virasakdi.(2020).Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China.Cancer management and research,12,
MLA:
Dai Jingyi,et al."Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China".Cancer management and research 12.(2020):6209-6220